Apriem Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.79M | Sell |
9,117
-3,319
| -27% | -$1.74M | 0.51% | 42 |
|
|
2025
Q1 | $7.89M | Sell |
12,436
-2,058
| -14% | -$1.31M | 0.92% | 32 |
|
|
2024
Q4 | $10.3M | Sell |
14,494
-1,033
| -7% | -$736K | 1.18% | 25 |
|
|
2024
Q3 | $16.3M | Sell |
15,527
-806
| -5% | -$847K | 1.91% | 13 |
|
|
2024
Q2 | $17.2M | Sell |
16,333
-4,390
| -21% | -$4.61M | 2.1% | 9 |
|
|
2024
Q1 | $19.9M | Sell |
20,723
-3,095
| -13% | -$2.98M | 2.51% | 8 |
|
|
2023
Q4 | $20.9M | Sell |
23,818
-1,099
| -4% | -$965K | 2.79% | 9 |
|
|
2023
Q3 | $20.5M | Sell |
24,917
-685
| -3% | -$564K | 3% | 8 |
|
|
2023
Q2 | $18.4M | Sell |
25,602
-505
| -2% | -$363K | 2.76% | 8 |
|
|
2023
Q1 | $21.5M | Sell |
26,107
-5,265
| -17% | -$4.33M | 3.43% | 7 |
|
|
2022
Q4 | $22.6M | Sell |
31,372
-876
| -3% | -$632K | 3.92% | 6 |
|
|
2022
Q3 | $22.2M | Buy |
32,248
+28
| +0.1% | +$19.3K | 4.01% | 6 |
|
|
2022
Q2 | $19M | Buy |
32,220
+82
| +0.3% | +$48.5K | 3.28% | 8 |
|
|
2022
Q1 | $22.4M | Buy |
32,138
+386
| +1% | +$270K | 3.29% | 5 |
|
|
2021
Q4 | $20.1M | Buy |
+31,752
| New | +$20.1M | 2.84% | 10 |
|
|
2017
Q2 | – | Sell |
-25
| Closed | -$10K | – | 450 |
|
|
2017
Q1 | $10K | Hold |
25
| – | – | ﹤0.01% | 421 |
|
|
2016
Q4 | $9K | Sell |
25
-20
| -44% | -$7.2K | ﹤0.01% | 451 |
|
|
2016
Q3 | $18K | Hold |
45
| – | – | 0.01% | 344 |
|
|
2016
Q2 | $16K | Hold |
45
| – | – | 0.01% | 366 |
|
|
2016
Q1 | $16K | Hold |
45
| – | – | 0.01% | 330 |
|
|
2015
Q4 | $24K | Hold |
45
| – | – | 0.01% | 275 |
|
|
2015
Q3 | $21K | Hold |
45
| – | – | 0.01% | 290 |
|
|
2015
Q2 | $23K | Buy |
45
+20
| +80% | +$10.2K | 0.01% | 303 |
|
|
2015
Q1 | $11K | Buy |
+25
| New | +$11K | ﹤0.01% | 405 |
|